Contrast Media Market 2020 Global Trend and Forecast to 2025 | E Healthcare, Bayer AG, Bracco Imaging S.p.A., Lantheus Medical Imaging, Diiachi Sankyo, Guerbet Group, nano Therapeutics Pvt. Ltd., Trivitron Healthcare, Spago Nanomedical AB, Subhra Pharma P

The global contrast media market was valued at USD 4,847.0 million in 2018. Increase in demand for diagnostic imaging procedures, increase in prevalence and mortality associated with chronic diseases coupled with rapid technological advancements in imaging modalities are the key factors driving the global contrast media market.

Request sample copy of this report at: https://www.adroitmarketresearch.com/contacts/request-sample/1207

Adroit Market Research report on global contrast media market gives a holistic view of the market from 2015 to 2025, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2015 to 2017, with the base year of estimation as 2018 and forecast from 2019 to 2025. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global contrast media market have been studied in detail.

Contrast media or contrast agents are used to improve images of the inside of the body produced by X-rays, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. The contrast media allows the radiologist to distinguish normal from abnormal conditions. Increase in demand for diagnostics and surging volume of image-guided procedures across the globe will boost the adoption of contrast media. Moreover, rapid technological advancements in imaging modalities along with rapid rise in prevalence and mortality associated with chronic diseases such as cancer, cardiac diseases, kidney disorders is anticipated to fuel the growth of the market in the future.

Read complete report at: https://www.adroitmarketresearch.com/industry-reports/contrast-media-injectors-market

The global contrast media market has been segmented based on product, modality, application, route of administration, and region. Based on product, the global contrast media market is categorized into iodinated, gadolinium-based, barium-based and microbubble contrast media. Iodinated contrast media dominated the global market in 2018 owing to increase in adoption of these agents in X-ray/computed tomography scans. On the basis of modality, the global contrast media market is segregated into X-ray/CT, magnetic resonance imaging (MRI), and ultrasound. On the basis of application, the global contrast media market is segmented into gastrointestinal disorders, cardiovascular diseases, cancer, neurological diseases, nephrological disorders, musculoskeletal disorders, and others. Cardiovascular diseases held majority of the market share in 2018. Based on route of administration, contrast media or contrast agents are segmented into intravascular, oral, rectal route, and others.

North America dominated the global contrast media market in 2018. Increase in volume of diagnostic imaging procedures, rapid technological advancement in imaging modalities, presence of well-established healthcare facilities, high prevalence of chronic disorders in the region are key factors likely to drive the growth of contrast media market in the next few years.

Major players operating in the global contrast media market include GE Healthcare, Bayer AG, Bracco Imaging S.p.A., Lantheus Medical Imaging, Diiachi Sankyo, Guerbet Group, nano Therapeutics Pvt. Ltd., Trivitron Healthcare, Spago Nanomedical AB, Subhra Pharma Pvt. Ltd., and CMC Contrast AB among others.

Get discount on purchase at: https://www.adroitmarketresearch.com/researchreport/purchase/1207

Key Segments of the Global Contrast Media Market

Product Overview, 2015-2025 (USD Million)

Iodinated contrast media
Gadolinium-based contrast media
Barioum-based Contrast Media
Microbubble Contrast Media

Application Overview, 2015-2025 (USD Million)

Cardiovascular Diseases
Cancer
Gastrointestinal Disorders
Nephrological Disorders
Neurological Disorders
Musculoskeletal Disorders
Others

Modality Overview, 2015-2025 (USD Million)

X-ray/CT
Magnetic Resonance Imaging (MRI)
Ultrasound

Route of Administration Overview, 2015-2025 (USD Million)

Intravascular
Oral
Rectal
Others

Regional Overview, 2015-2025 (USD Million)

North America
U.S.
Canada
Europe
Germany
United Kingdom
France
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market's size, key trends, participants and future outlook of an industry. We intend to become our clients' knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code- Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Ryan Johnson
Account Manager Global
3131 McKinney Ave Ste 600, Dallas,
TX75204, U.S.A.
Phone No.: USA: +1 972-362 -8199/ +91 9665341414

This release was published on openPR.